195 related articles for article (PubMed ID: 8991238)
41. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of antibodies to Borrelia burgdorferi in European bison (bison bonasus) from Białowieza Primeval Forest.
Siński E; Gill J; Rijpkema S
Rocz Akad Med Bialymst; 1996; 41(1):111-6. PubMed ID: 8673795
[TBL] [Abstract][Full Text] [Related]
43. Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
Lyamuya EF; Matee MI; Kasubi M; Scheutz F
East Afr Med J; 1999 Jul; 76(7):370-5. PubMed ID: 10520363
[TBL] [Abstract][Full Text] [Related]
44. [Detection of anti-BB antibodies in human sera by VIDAS system].
Guan S; Yin G; Han S
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):368-71. PubMed ID: 7874709
[TBL] [Abstract][Full Text] [Related]
45. Determination of antibodies to Borrelia burgdorferi in the serum of patients living in Calabria, southern Italy.
Santino I; Dastoli F; Lavorino C; Navazio M; Nicosia R; Oliveti A; Oliveti G; Pustorino R; Sessa R; Del Piano M
Panminerva Med; 1996 Sep; 38(3):167-72. PubMed ID: 9009681
[TBL] [Abstract][Full Text] [Related]
46. [Lyme borreliosis].
Stanek G
Wien Med Wochenschr; 1995; 145(7-8):155-61. PubMed ID: 7610663
[TBL] [Abstract][Full Text] [Related]
47. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G
J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398
[TBL] [Abstract][Full Text] [Related]
48. [The prevalence of Borrelia burgdorferi antibodies in a population at risk].
Oteo JA; Martínez de Artola V; Fernández Calvo JL; Casas JM; Rivero A; Grandival R
Rev Clin Esp; 1990 Oct; 187(5):215-7. PubMed ID: 2102530
[TBL] [Abstract][Full Text] [Related]
49. [Laboratory methods for the diagnosis of clinical forms of Lyme borreliosis].
Assous MV
Med Mal Infect; 2007; 37(7-8):487-95. PubMed ID: 17408896
[TBL] [Abstract][Full Text] [Related]
50. [Interpretation of borreliosis serology. Step-wise diagnosis--introduction to case examples].
Hassler D; Maiwald M
Fortschr Med; 1998 Oct; 116(29):20-2, 24. PubMed ID: 9846470
[No Abstract] [Full Text] [Related]
51. [A clinico-serological study of Lyme disease in the northwestern USSR].
Anan'eva LP; Korenberg EI; Skripnikova IA; Soldatkina LM; Nasonova VA
Med Parazitol (Mosk); 1990; (6):28-31. PubMed ID: 2290396
[TBL] [Abstract][Full Text] [Related]
52. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
[TBL] [Abstract][Full Text] [Related]
53. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.
Bluth MH; Robin J; Ruditsky M; Norowitz KB; Chice S; Pytlak E; Nowakowski M; Durkin HG; Smith-Norowitz TA
Scand J Immunol; 2007 Apr; 65(4):376-82. PubMed ID: 17386029
[TBL] [Abstract][Full Text] [Related]
54. Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: survey of patients seen in general practice.
Dessau RB; Bangsborg JM; Ejlertsen T; Skarphedinsson S; Schønheyder HC
BMC Infect Dis; 2010 Nov; 10():317. PubMed ID: 21040576
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis of Lyme borreliosis: non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies.
Seppälä IJ; Kroneld R; Schauman K; Forsen KO; Lassenius R
J Med Microbiol; 1994 Apr; 40(4):293-302. PubMed ID: 8151682
[TBL] [Abstract][Full Text] [Related]
56. [Lyme neuroborreliosis in More and Romsdal].
Eldøen G; Vik IS; Vik E; Midgard R
Tidsskr Nor Laegeforen; 2001 Jun; 121(17):2008-11. PubMed ID: 11875896
[TBL] [Abstract][Full Text] [Related]
57. [The experience of a serological examination of the rural population in a territory endemic for Lyme borreliosis].
Korenberg EI; Kalinin MI; Skripnikova IA; Soldatkina LM
Med Parazitol (Mosk); 1990; (3):15-6. PubMed ID: 2145501
[TBL] [Abstract][Full Text] [Related]
58. [Endemic threat of Lyme borreliosis in Bialowicza forestry area].
Flisiak R; Prokopowicz D; Flisiak I; Bobrowska E; Miegoć H; Grzeszczuk A; Sulik E; Okolów C
Przegl Epidemiol; 1994; 48(3):211-7. PubMed ID: 7938624
[TBL] [Abstract][Full Text] [Related]
59. Geographical differences in seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011-2013.
Vestrheim DF; White RA; Aaberge IS; Aase A
Ticks Tick Borne Dis; 2016 Jul; 7(5):698-702. PubMed ID: 26961275
[TBL] [Abstract][Full Text] [Related]
60. [The epidemiological aspects of Lyme borreliosis in Sverdlovsk Province].
Lesniak OM; Ponomarev DN; Volkova LI; Il'ina NS; Laĭkovskaia EE; Dvoskina BIa
Med Parazitol (Mosk); 1995; (1):7-10. PubMed ID: 7770026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
